Clinical Trial 38750

Long Beach, CA 90806


Summary:

This is a double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.


Qualified Participants Must:

• Be diagnosed with Alzheimer's and be 65 to 90 years old


Qualified Participants May Receive:

Compensation for time and travel, may receive investigational medication or placebo.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.